NewTimeSpace News: On 12 August 2026, TH MEDICAL-B (02697.HK) announced that it was confirmed as the winning supplier for a research equipment procurement project of Yunnan Agricultural University (Project No.: YNGH[2026]-0626), covering one set of multi-organ multi-sensor normothermic perfusion system with built-in ventilator, with a total transaction amount of RMB 2.8 million.
NewTimeSpace News: On 12 August 2026, ACOTEC-B (06669.HK) issued a profit warning, expecting a net loss of not more than RMB 80.9 million for the six months ended 30 June 2026, versus a net profit of approximately RMB 88.6 million in the same period of 2025, mainly due to the termination of the U.S. clinical project for the AcoArt Litos paclitaxel-coated PTA balloon catheter, which triggered one-off impairment and expense provisions totaling approximately RMB 150.8 million.
NewTimeSpace News: On 12 August 2026, Asia Properties & Finance (00271.HK) issued a profit warning. The Group expects the net loss for the six-month period ending 30 June 2026 to range from approximately HK$110 million to HK$120 million, widening from around HK$63 million in the corresponding period of 2025, mainly due to a larger fair value reduction of investment properties.
NewTimeSpace News: On 12 August 2026, New Silk Road Holdings Group (00472.HK) released a profit forecast. The Group expects its net loss for the six-month period ending 30 June 2026 to narrow to approximately HK$13.9 million to HK$17.0 million, compared with around HK$41.7 million recorded in the same period of 2025, mainly due to lower impairment loss on goodwill.
NewTimeSpace News: On 12 August 2026, BQD (03866.HK) announced that the Qingdao Regulatory Bureau of the National Financial Regulatory Administration approved Mr. Zhang Shixing's qualification as an independent non-executive director of the Bank (Qing Jin Fu [2026] No. 158); he assumed office from 10 August 2026, while Mr. Fan Xuejun ceased to hold the relevant positions.
NewTimeSpace News: On 12 August 2026, OSL GROUP (00863.HK) announced the appointment of Mr. Wong Koon Man as executive director with effect from 12 August 2026.
NewTimeSpace News: August 12, 2026, POU SHENG INT'L(03813.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 8.96 billion, decreased by 2.13% YoY.
NewTimeSpace News: August 12, 2026, CKI HOLDINGS(01038.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 2.07 billion, decreased by 6.16% YoY.
NewTimeSpace News: August 12, 2026, QIANHAI HEALTH(00911.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 116.76 million, decreased by 65.74% YoY
On 12 August, Hong Kong's three major indices weakened across the board, with the Hang Seng Index down 0.83% at 25,440.17 points, the Hang Seng TECH Index down 0.99%, and turnover of HKD 216.779 billion. Property stocks strengthened, with CHINA JINMAO up 13.92% and YUEXIU PROPERTY up 9.99%, as Beijing's new property policies were implemented. Memory chip and optical communication concepts were active, with MONTAGE TECH up 7.60% and KB LAMINATES up 10.70%. Most tech stocks corrected, with TENCENT MUSIC-SW down 12.55%. Southbound capital recorded net selling of HKD 2.906 billion. MINIMAX-W surged 8.96% against the trend and HUA HONG GRACE rose 7.13%. GALAXY ENT's interim dividend increased nearly 30%, and NSING TECH raised prices of some chips by 10% to 20%.
NewTimeSpace News: On 12 August 2026, IMPACT THERAP-B (07630.HK) announced the nomination of IMP2794 as a preclinical candidate compound, the first KAT6A-specific PROTAC degrader discovered through its self-owned targeted protein degradation platform, with over 1,000-fold selectivity over KAT6B, excellent in vivo anti-tumour efficacy in breast cancer CDX models and high oral bioavailability.
NewTimeSpace News: On 12 August 2026, the Stock Exchange of Hong Kong Limited announced that the listing status of RENCO HOLDINGS (02323.HK) will be cancelled under Rule 6.01A(1) of the Listing Rules with effect from 9:00 a.m. on 17 August 2026. Shares have been suspended since 20 January 2025, and the Company failed to resume trading by the 19 July 2026 deadline; the Listing Committee decided to delist the Company on 31 July 2026.
NewTimeSpace News: On 12 August 2026, SIRNAOMICS-B (02257.HK) announced the completion of a subscription under general mandate, with 2,435,600 new shares allotted and issued at HKD 4.69 per share, representing approximately 2.17% of the issued shares immediately after completion. Net proceeds of approximately HKD 11.3 million will be used as general working capital.
NewTimeSpace News: On 12 August 2026, ZHAOKE OPHTH-B (06622.HK) announced an exclusive distribution and promotion agreement with Pengpai Biomedical for its independently developed Emedastine Hydrochloride Eye Drops (a generic version of Elestat approved in November 2025), covering all sales channels in China. The initial cooperation term is five years, automatically renewable to ten years upon achieving an 80% cumulative procurement target.
NewTimeSpace News: On 12 August 2026, LINMON MEDIA (09857.HK) announced that Mr. Zhang Rong resigned as non-executive director and audit committee member, and Mr. Zheng Jiaming was appointed in his place with effect from 12 August 2026. Mr. Zheng currently serves as managing director of the consumption business unit of Hony Capital, with an initial term of three years.
NewTimeSpace News: On 13 August 2026, JIANGSU EXPRESS (00177.HK) announced the issuance of the 10th tranche of 2026 super short-term commercial paper of RMB 590 million on 11 August 2026, at an issue rate of 1.41%, with a tenor of 261 days and maturity on 30 April 2027. The tranche was fully subscribed by 6 compliant and 6 valid subscribers, with China CITIC Bank as bookrunner and lead underwriter.
